Express Pharma

ACTA Down, But what next?

The EU parliament has rejected the Anti-Countefeiting Trade Agreement (ACTA) but there are other similar moves to restrict free…

Moving with the market

Viveka Roychowdhury reports on the successful right sizing of strategies by both pharma MNCs and their Indian counterparts

Nurturing India’s small biotech

With India's DBT committing 30 per cent of its budget to PPPs, will these fund an ecosystem for small and medium sized companies…